Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well I do and just being real. Planning to buy more if it goes to .03. I've been buying steady from .015 through .055. March is only 1 more day away. It's also a long month and it could go to .10 if news comes out. But for this week it will be interesting based on the momentum. Take a deep breath, put on your seatbelt and enjoy the ride.
What is holding this back?
I see this going up past $10 on Wednesday if Trump talks about infrastructure on Tuesday night.
To whatarush12: I'm not a short. I own way too many shares and are very long on the company. I'm only judging the momentum of the stock. At this stage we need news and real sales to make the stock move significantly. I think it will consolidate between .025 and .03 before it can start moving up again. This technology with the right partners will go far, but I think it will take years before we see the kind of returns that all longs are expecting.
I say we touch 3.25 tomorrow. This dilution will take some time to sort out......
I'm thinking this will easily touch the low 3's or high 2's tomorrow. Opportunity to buy more for those that are patient and can hang on for a few months to get a great return.... or....hang for a few years and get an astronomical return. This stock needs news to pump, otherwise it just sinks lower and lower each day.
Lets hope Vdrm hasn't missed any of the $1000 per month payments to Phillips to maintain the rights.
Based on what? You won't see that kind of share price until well after April. This needs sales to move to .10 or .15. This technology has potential and the stock price has already priced in. Now sales are the key to move the share price.
I wouldn't be surprised if this stock tested the low 3's before it takes off again. Watching closely for chance to buy more. With no news there are not any significant sales to make the stock move up.
Just buy more at every opportunity and hold for the buy out from big pharma.
So its like a commercial for a product.....thanks
Anyone know what a "poster session" is? Interesting developments.
I see what the article states, but what Otiko said in the interview is something different regarding revenues. I hope there are sales of 500k units. It would be very significant for the share value by late 2017 or early 2018.
I think the sales projections you show for 2017 are not correct. In the web interview, Otiko spoke about sales $'s at 500k to 1M for 2017. You have indicated sales units rather than sales $ in your analysis. At Otiko's sales projections the stock will have difficulty sustaining a PPS above .10 and it will be a long while before the company takes off. I am very long on this stock and willing to wait for the return that everyone is expecting.
Really? I wish it could break $70
This stock is slowly dying. Can't believe it's this bad considering all the positive news a few months ago.
Is vcel making any money?
I think I'll buy some when it goes below 3.50. Not much momentum since the private offering. It may take a while before it see's $5 again. It may even go to the low 3's before it turns around. We need good sales #'s. Keep long!
Really you plan to exit at .50? You must own a few millions shares....this can go to many $'s once distribution gets going. If this is the real deal, Vdrm can go to $20 or more once the company licenses its product. I would hold until at least $10 then think about slowly pulling out some gains. There is much potential in so many treatments, unlike any other biotech out there.
Can someone post the actual study that Vdrm did....? The website shows only before and after pictures. I would like to read the study itself...... I own way too many shares and I am not selling.....very long on this stock.
My guess is the next news we hear is that a private equity firm buys the company for mini pennies on the dollar - and in a few months the private equity firm will flip the company and its technology for many many millions. There must be something going on behind the scenes.
Let's hope you are right about the revenue. I still think this will waddle around .015 or so until real news breaks.
That's not a lot of revenue for 2017. This may go up, but will come back down quickly until more substantial news comes out. Wow I thought the revenue would be much higher with all the news on this.
$20-30 is a pipe dream. If things go well it will be bought out by the big boys before it hits $10 and investors will get cash. That's how these small companies trade. When there is massive upside they get gobbled up so the big boys make all the real money.
All those who bought under a penny are selling for profits. Soon we may also get an opportunity to buy under a penny. Let's see.
I hope you're right, but the momentum right now is towards .01.
All I'm trying to say that a $3.50 offering is not good for investors that bought at $5 the day before the news came out. This negative momentum may drive the stock below $3.50 possibly close to $3 in the very short term.
This will go to $3 before it kicks back up. I can't see why people are buying at $4 when there is a $3.50 offering out there. Doesn't make sense.
I think this will test the .01-.015 levels until more news comes out and start a serious uptrend. There are too many that bought under a penny and there is a lot of profit taking going on. Short sighted on their part.
Vdrm should zoom past .10 after more news in March. Could go to $1 by year end as sales pile up. Big pharma will make a play in 2018 - let's hope we don't sell out for a only a few $ per share. This company has potential to trade way north of $10 as sales pick up in just a year or two at the most. There are many other biotech firms trading much higher with less.